Home / Europe / Germany / Labor, Employment & Pensions / Directors & Benefits

Directors & Benefits

Re­mu­ner­a­tion, ESOP/VSOP, Su­per­vis­ory council and board level advice, ESG, etc.

Back to Labor, Employment & Pensions

For English translation please switch on subtitles.

Case Study | From many to one: harmonisation of company-wide remuneration structures

Everyone doing their own thing on remuneration: that was the situation facing our client, a listed company in a regulated sector, when they sought our advice. The business had grown internationally via a number of acquisitions, but without aligning the widely disparate remuneration systems. 

Remuneration as a business fairness issue

The resulting patchwork of remuneration regimes led to considerable organisational challenges for HR. It also proved to be a source of unease among employees, who found the different remuneration criteria difficult to understand. This led to growing dissatisfaction that threatened to undermine the organisation’s long-term human resources policy.

Starting point: thorough market analysis

Although it was recognised that remuneration needed to be reformed, the works council had major reservations. It was concerned that remuneration would in effect be cut and it wanted to preserve employees’ existing rights. To put the discussion on an objective footing from the start, we carried out comprehensive market analysis (among other work) prior to dealing with the legal aspects. This research was based on the following questions: What is the average remuneration in the relevant sector? Which remuneration components and remuneration instruments are customary in the sector? What are the longer-term forecasts for remuneration in the sector? By taking this objective look at the market situation, we were able to steer the works council away from a range of unrealistic ideas ahead of the actual negotiations. We benefited here from our broad market knowledge, gained through a large number of remuneration projects, and from our close links to leading remuneration consultancies.

Long-term remuneration models: key contributors to a sustainable business

Market analysis was followed by long-term structuring. Remuneration models often suffer from short-termism, which is problematic because remuneration is a key element in corporate fairness and of central importance for employee retention. Variable remuneration in particular, with its many structuring options – such as short-term and long-term incentives (especially stock option programmes, virtual share programmes and carry agreements) – helps to strengthen employee commitment to the company’s success and in turn boosts loyalty. 
Working closely with our client, we concluded that in addition to fixed remuneration and annual bonuses, the most appropriate option seemed to be a long-term virtual share programme, given the company’s objectives and its peers in the market. Our client chose to embrace an innovative approach here. To incentivise staff, it decided to allow a broad range of employees to participate in the virtual share programme, rather than just senior managers. 

The fact that the virtual share programme provides employees with a substantial financial opportunity ultimately also won over the works council. In return, skilful negotiation on our part persuaded the works council to accept a significant tightening of the previously very “loose” conditions for annual bonuses, as well as the introduction of a bonus pool to be determined annually by the company. Our client can now respond to economically challenging times by reducing the bonus pool and setting tougher targets, thereby avoiding uncomfortably high payouts.

Careful legal structuring is key

Even the best plan is useless without sound legal structuring. Case law on remuneration shows that the courts are extremely strict. The slightest lack of precision in how the scheme is implemented can quickly lead to the employer being defeated, with significant economic consequences. That applies not only to employment contracts, but also to workplace agreements, which are typically subjected to close scrutiny. In addition, this area of law is currently undergoing extreme change: flexibility instruments such as malus clauses, clawback clauses, qualifying-date arrangements, vesting provisions, good leaver/bad leaver clauses and bonus pools are all generating controversy both nationally and internationally. Thanks to our close involvement in the latest discussions around remuneration law, our long-standing partnership with leading remuneration advisors and our work on major projects, we have the advantage of being highly attuned to emerging developments. Accordingly, we were able to present our client with the very latest structuring options in the above-mentioned project. International aspects were covered in conjunction with our colleagues from the worldwide CMS organisation.

Regulation in the mix

Our client faced the additional challenge of operating in a regulated sector. It was therefore necessary to tailor remuneration to meet strict regulatory requirements; existing remuneration policies also had to be adjusted. Together with members of our remuneration team who are experts in regulatory matters, we guided our client safely through the pitfalls. Our experts also provided support around the discussions with the Federal Financial Supervisory Authority (BaFin). These team members benefit from also being in constant contact with the authority’s staff in connection with projects outside of employment law.

Transparent information

Following negotiations with the works council, extensive consultation with BaFin and drafting of the relevant documents, the crucial question was how employees would react to the new remuneration scheme. Since some of the employees’ existing contracts did not allow amendment by way of a workplace agreement, supplementary agreements needed to be added to employment contracts to safeguard implementation of the remuneration system. We helped to stage information events that provided a high level of transparency and proved hugely successful, with all employees signing the proposed supplementary contracts. 

New remuneration packages also for the management board

Lastly, our client wanted to reform board member remuneration and make it part of the new system, rather than restricting the scheme to employees. In this context, it was particularly important to our client’s supervisory board to implement the recommendations of the new Corporate Governance Code (including clawback clauses, deferrals and remuneration caps). The new requirements imposed by the Act Implementing the Second Shareholder Rights Directive (Gesetz zur Umsetzung der zweiten Aktionärsrechterichtlinie, ARUG II) also had to be taken into account. This involved working closely with our experts in stock corporation law; we regularly pool our knowledge to advise companies on board matters. We also drafted the remuneration report, assisted by our stock corporation lawyers. Its approval by the annual general meeting meant that the remuneration system we advised on was also accepted by the shareholders.

Delivering one-stop advice on remuneration

It was an ambitious instruction. The objective was not just to restructure individual aspects of remuneration for specific groups of employees, but to restructure the entire remuneration system for employees and board members alike and to apply modern remuneration criteria. Alongside individual and collective employment law issues, this also involved dealing with stock corporation law, regulation and tax law. Our ability to provide one-stop advice on major projects of this type is down to an established remuneration team that includes experts on employment law, regulatory law, stock corporation law and tax law. This holistic approach enabled us to bring the above project to a successful conclusion for our client in a timely and efficient manner. Our client now has a sustainable, modern and competitive remuneration system in place, making it well positioned to face the future.

Remuneration models require two things: in-depth market knowledge and careful legal underpinning.


Feed

02/05/2024
"Automatically disadvantaged?" – Discrimination in the use of AI in the...
Despite the enormous potential of artificial intelligence (AI) in the workplace, evidence shows that AI harbours the risk of perpetuating discriminatory decision-making patterns. There are increasing...
23/04/2024
Artificial Intelligence and Occupational Health and Safety – Opportunities...
This article looks at both the opportunities and risks presented by using artificial intelligence with regard to occupational health and safety.AI has become an integral part of the modern working world...
17/04/2024
Impact of the CJEU's Schufa judgment on the use of AI in HR
This article examines the extent to which the CJEU's Schufa judgment is an obstacle to the use of artificial intelligence (AI) in the HR sector.More and more companies are using AI systems in HR. A key...
15/04/2024
CMS advises Silver Investment Partners on setting up COHEMI Group
Frankfurt/Main – Consulting firms SIRIUS Consulting & Training, Acuroc Solutions and IQ Solutions have joined forces and will operate as members of the COHEMI Group going forward. The newly formed group will focus on IT, process and organisational consulting services. The aim is to jointly leverage the growth opportunities in the market and create economies of scale at group level. The planned growth will be supported by an investment from Silver Investment Partners (SIP), an independent equity finance investor specialising in medium-sized companies. The existing management of all three companies will remain both operationally and financially involved.A CMS team headed by lead partner Dr Peter Polke advised SIP on all legal aspects of acquisitions made in connection with structuring and expanding the majority stake in the COHEMI Group. Dr Peter Polke previously advised SIP during his time at King & Wood Mallesons. The private equity specialist moved from KWM to CMS with effect from 1 January 2024 and is now reinforcing the private equity practice at CMS. Based in Königstein im Taunus, SIP is an independent equity finance investor for medium-sized companies in Germany, Austria and Switzerland. As an entrepreneurial, experienced and trusted partner, Silver Investment Partners takes majority and minority stakes in companies with revenues of between EUR 5 and 100 million, with a focus on companies in the EUR 10 to 50 million range. The COHEMI Group comprises SIRIUS Consulting & Training GmbH, Acuroc Solutions GmbH and IQ Solutions GmbH. Their operational businesses currently employ almost 100 consultants across four locations in Germany, with the headquarters in Frankfurt am Main. The consulting group’s main focus at present is on IT governance, IT project management, (IT) service management, change management, asset strategy & performance management, data management and software asset and license management. The group intends to steadily expand its portfolio by pursuing a long-term buy-and-build strategy. CMS Germany Dr Peter Polke, Lead Partner Dr Dirk Baukholt, Principal Counsel Hanno Brandt, Senior Associate Julian Buhr, Legal Coordinator, all Corporate/M&A Carsten Domke, Partner Jonas Hötzel, Associate, both Labor, Employment & Pensions Philipp Lotze, Partner Theresa Lenger, Senior Associate, both IP/IT Stefan Lehr, Partner, RegulatoryPress Con­tact presse@cms-hs. com
15/04/2024
Co-determination in the setup and organisation of whistleblower reporting...
This article deals with the co-determination rights of the works council as regards whistleblower reporting offices in accordance with the German Whistleblower Protection Act (HinSchG).The legislator...
10/04/2024
Podcast CMS To Go | KI-Verordnung: Was Arbeitgeber wissen müssen
The EU’s AI Regulation aims to promote the introduction of human-centred and trustworthy artificial intelligence in Europe. But what is the content of this much-discussed new framework and what is its purpose? What implications does it have for employers and for the use of AI within companies? Will the goal of the legislation actually be achieved or is the opposite likely to be the case? In a new "Employment law made simple" podcast, Dr Inka Knappertsbusch and Patricia Jares address these questions and many other interesting issues. Have a listen.
08/04/2024
CMS advises Panasonic Europe on reformation of European governance structure
Hamburg – Panasonic, one of the world's leading electronics manufacturers, has changed parts of its organizational set-up towards a new governance structure for certain of its European entities. They opened new branch offices under its Dutch European headquarter entity, Panasonic Europe B.V. in the UK, Spain and Poland. In Spain and Poland, the staff and certain assets of the existing branch offices of German Panasonic Marketing Europe GmbH have been transferred to the new branches as of 1 April 2024. An international CMS team led by Dr Eckart Gottschalk and Dr Philipp Koch provided comprehensive legal advice to Panasonic on this transaction. The focus was on corporate and employment law advice and the coordination of the various steps in different jurisdictions. CMS Germany worked once again closely with CMS firms from the UK, Spain, Poland and the Netherlands. With its renewed organizational set-up, Panasonic is streamlining its governance structure across Europe. The Panasonic Group, founded in 1918, is today a global leader in developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, industry, communications and energy sectors worldwide. The Panasonic Group switched to an operating company system on April 1, 2022 with Panasonic Holdings Corporation serving as a holding company and eight companies positioned under its umbrella. The Group reported consolidated net sales of 8,378.9 billion yen (approx. 59.4 billion Euro) for the year ended March 31, 2023. CMS Germany Dr Eckart Gottschalk, Lead Partner, Hamburg Dr Philipp Koch, Counsel, Hamburg Sonja Schanze, Associate, Hamburg Tjorben Drawe, Associate, Hamburg, all Corporate/M&A Dr Daniel Ludwig, Partner, Hamburg Dr Jacob Hinze, Counsel, Hamburg, both Employment law CMS UK Nick Crosbie, Partner, London George Yuill, Senior Company Secretary, London, both Corporate/M&A CMS Spain Luís Miguel de Dios, Partner, Mad­rid Aleksandra Czajka, Senior Associate, Madrid, both Corporate/M&A María José Ramos Aguilar, Senior Associate, Madrid, Employment law CMS Poland Olga Czyzycka-Szczy­giel, Counsel, Warsaw Magdalena Mentrak, Associate, Warsaw, both Corporate/M&A Michał Tutaj, Senior Associate, Warsaw, Employment law CMS Netherlands Britt Straat, Candidate civil law notary, Amsterdam Panasonic Europe Volkhard Pfaff, General Counsel, Wies­baden Daniela Gardiner, Head of Legal Local Sales Operations, Brack­nell Claudia Neif, Head of Legal DACH, Wies­baden Paulina Prugar, Senior Legal Counsel, Warsaw Jaime Corderas, Senior Legal Counsel, Barcelona Markus Rein, HR-Director, Ham­burg Chris­ti­an Konertz, Employee & Labor Relations Manager, HamburgPress Con­tact presse@cms-hs. com
02/04/2024
CMS advises Main Street Capital Corporation on the acquisition of Maass...
Ham­burg/Stut­tgart – Main Street Capital Corporation, a publicly traded financial investor based in Houston, Texas, has acquired Maass Global Group through one of its portfolio companies, Gulf Manufacturing, LLC. The Essen-based company is a global leader in the manufacture and sale of flanges and forged specialty products, forged steel bars, seamless tubes and fittings made of duplex, stainless steel and high-nickel alloys. In addition to its headquarters in Essen, the Maas Global Group has further locations in the Netherlands, the United Kingdom, India, Singapore and the United Arab Emirates.A CMS team led by Dr. Eckart Gottschalk and Dr. Kai Wallisch provided comprehensive legal advice to Main Street Capital Corporation on this transaction. In addition to corporate law advice, the focus was on the legal implementation of the financing. As part of the transaction, CMS Germany worked closely with CMS law firms from the Netherlands, Singapore and the United Arab Emirates as well as the American law firm Locke Lord and AZB & Partners from India. Main Street Capital Corporation is a publicly traded investment company with a market capitalization of approximately USD 3.9 billion. It specializes in long-term financing of middle-market companies in various industries through management buyouts, re­cap­it­al­iz­a­tions, growth financing and acquisitions. With the investment to acquire Maas Global Group, Main Street Capital Corporation is deepening its existing investment in the manufacturing of flanges, fittings and other specialty products for industrial applications. CMS Germany Dr. Eckart Gottschalk, Lead Partner Dr. Kai Wallisch, Lead Partner Dr. Paul Kintrup, Senior As­so­ci­ate Mil­itsa Decheva Petrova, Senior Associate Dr. Alexander Weinhold, Senior As­so­ci­ate Tjorben Drawe, Associate Sonja Schanze, As­so­ci­ate Kath­rin Dengel, Associate, all Corporate/M&A Dr. Marc Seibold, Partner Anne Waßmuth, Counsel Carla Kaeber, Associate, all Banking & Finance Dr. Hans Fabian Kiderlen, Principal Counsel Theresa Friedle, Associate, both Real Estate & Public Dr. Michael Kraus, Partner Thomas Fröhlich, Counsel, both TMC Dr. Jacob Hinze, Counsel, Employment Law Dr. Martin Mohr, Partner, Tax Christoff Henrik Soltau, Partner Dr. Robert Bodewig, Senior Associate, both Antitrust, Competition & Trade Kai Neuhaus, Partner Moritz Pottek, Counsel, both Brussel EU Law Office CMS Netherlands Roman Tarlavski, Partner Maarten Feenstra, Associate Fleur Assendelft de Coningh, Associate Anne Fleur Krijthe, Candidate civil law notary CMS Singapore Toby Grainger, Partner Leslie Tay, Associate CMS UAE Patrik Daintry, Partner Fawzi Oueidat, Associate Locke Lord Greg Heath, Partner Nicholas Jennings, Partner Jason Ulezalka, Partner Case Towslee, Associate Jake Chagoury, Associate Mason Marek, Associate AZB & Partners Srinath Dasari, Senior Partner Gautam Rego, Partner Yash Anand, Associate Gopika Menon, AssociatePress Con­tact presse@cms-hs. com
26/03/2024
CMS advises SEFE on all aspects of acquiring WIGA Group
Hamburg – SEFE Securing Energy for Europe GmbH (SEFE) has acquired all the shares in WIGA Transport Beteili­gungs-GmbH & Co. KG (WIGA) from its co-shareholder Wintershall Dea AG. The transaction is currently awaiting approval from the competition authorities. SEFE is wholly owned by the Federal Republic of Germany. WIGA owns regulated gas pipeline operators GASCADE Gastransport GmbH and NEL Gastransport GmbH, who operate one of the largest high-pressure gas networks in Germany with a combined length of around 4,150 kilometres. These networks have a key role to play in European energy security and the green energy transformation. The transaction will strengthen SEFE in its role of ensuring secure and reliable energy supply in Germany and Europe, as well as boosting its hydrogen ex­pert­ise.“With the full acquisition of WIGA as sole shareholder, we are strategically strengthening SEFE as an independent and autonomous midstream company,” commented Reinhard Gorenflos, Chairman of the SEFE Supervisory Board.“SEFE being the sole shareholder of WIGA will ensure that GASCADE can convert the existing high-performance infrastructure to hydrogen in the future. In this way, we can help drive forward the green energy transformation. Transportation infrastructure is a pivotal part of the future hydrogen value chain,” said Dr Egbert Laege, CEO of SEFE. “The two WIGA subsidiaries, GASCADE and NEL, will continue to operate independently and market their capacity in a transparent and non-dis­crim­in­at­ory manner.”SEFE CFO Dr Christian Ohlms highlighted the importance of WIGA with regard to the privatisation of SEFE, which is due to take place by the end of 2028: “With this transaction, which is expected to complete by summer 2024, we are strengthening SEFE’s asset base. Our aim is to continue the long-term development of SEFE on a stable financial footing.”A multinational CMS team headed by Hamburg-based partner Dr Holger Kraft advised SEFE on all aspects of acquiring WIGA. In addition to extensive due diligence on the entire WIGA Group, including GASCADE and NEL, which are regulated under energy law, this work covered negotiation of the share purchase agreement and separate agreements with the shareholders of Wintershall Dea AG. Alongside negotiating the transaction agreements, the advice focused on safeguarding the transaction through several W&I insurance agreements, including negotiating the policies, and handling regulatory issues relating to gas network operation and other public-law matters. CMS Germany worked closely with the CMS law firms in the UK and Luxembourg, and with US law firm Faegre Drinker Biddle & Reath LLP. CMS previously advised the Federal Network Agency (BNetzA) and the Federal Ministry for Economic Affairs and Climate Action in 2022 and 2023 around their trusteeship over SEFE and its subsequent nationalisation by way of corporate actions. The instructions for this transaction followed on from that successful cooperation. About SEFE:As an integrated midstream energy company headquartered in Berlin, SEFE Securing Energy for Europe ensures the security of energy supply in Germany and Europe and is driving the green energy transformation. SEFE is active in trading & portfolio management, sales, transportation and storage of energy and has its strongest presence in Germany and the UK. SEFE employs around 1,500 people and supplies over 50,000 customers, in particular industrial customers and municipal utilities in Germany and seven other European markets. With a sales volume of around 200 TWh of power and gas, SEFE plays a central role in stability of the energy supply in Germany and Europe. SEFE is owned by the Federal Government of Germany. CMS Germany Dr Holger Kraft, Lead Partner Dr Jan Schepke, Partner Matthias Sethmann, Principal Counsel Dr Dirk Baukholt, Principal Coun­sel Char­lotte von der Heydt-von Kalckreuth, Counsel Dr Stefan Kühl, Senior Associate Dr Paul Kintrup, Senior Associate, all Corporate/M&A Dr Rolf Hempel, Partner Dr Friedrich von Burchard, Partner Nicole Köppen, Senior Associate, all Regulatory Dr Hermann Müller, Partner Dr Arno Görlitz, Associate, both Public Commercial Law Dr Martin Mohr, Partner Dr Olaf Thießen, Principal Counsel, both Tax Dr Alexandra Schluck-Amend, Partner Manuel Nann, Senior As­so­ci­ate Pit-Jo­hannes Wagner, Associate, all Restructuring Dr Andreas Hofelich, Partner Dr Mario Brungs, Counsel Dr Lena Pingen, Associate, all Em­ploy­ment/Pen­sions Dr Fritz von Hammerstein, Partner Jan Gröschel, Senior Associate Heike Weyer, Senior Associate, all Public Law Dr Stefan Voß, Partner Tamara Bux, Associate, both Real Estate Dr Sebastian Cording, Partner Martin Krause, Partner Dr Shaya Stender, Associate Joel Coché, Associate, all Commercial Dr Julia Runge, Principal Counsel, Finance Dr Michael Bauer, Part­ner Chris­toff Henrik Soltau, Partner Dr Robert Bodewig, Senior Associate Luisa Thomasberger, Associate, all Antitrust, Competition & Trade CMS UK Russel Hoare, Partner Sam De Silva, Part­ner Jean-Fran­cois Willems, Of Counsel Jennifer Louch, Senior As­so­ci­ate Max­imili­an Weaver, Senior Associate Louisa Mottaz, Associate CMS Luxembourg Angelique Eguether, Senior As­so­ci­ate Guil­laume Flagollet, Managing Associate Faegre Drinker Biddle & Reath LLP (USA) Mollie D. Sitkowski Inhouse at SEFE Securing Energy for Europe GmbH Dr Jörg Kammerer Jörn RimkePress Con­tact presse@cms-hs. com
26/03/2024
CMS advises sellers of Cardior Pharmaceuticals on potential acquisition...
Munich – CMS advises the sellers of Cardior Pharmaceuticals in the potential acquisition of the company by Novo Nordisk. Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart failure. The closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions. It is expected to happen in the second quarter of 2024.A CMS team headed by Lead Partners Stefan-Ulrich Müller, Dr Tilman Weichert and Jörg Schrade advised the sellers of Cardior Pharmaceuticals on all legal aspects of the transaction. Cardior Pharmaceuticals GmbH, based in Hannover, Germany, is a leading clinical-stage bio­phar­ma­ceut­ic­al company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. The company’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. CMS Germany Stefan-Ulrich Müller, Lead Partner Dr Tilman Weichert, Lead Partner Dr Michael Wangemann, Partner Dr Kai Wallisch, Partner Dr Thomas Mühl, Principal Coun­sel Se­basti­an Hummel, Senior As­so­ci­ate Vikt­or­ia Barthel, Senior As­so­ci­ate Mar­i­elouise Emmer, Senior Associate Dr Carl-Friedrich Thoma, Senior Associate Dr Stefan Kühl, Senior Associate Dr Alexander Weinhold, Senior Associate Maria Kucher, Associate Jonas Ohmann, Associate Dr Josephine Doll, Associate Dr Christian Seeburger, Associate Sonja Schanze, Associate, all Corporate/M&A Dr Marie-Luisa Loheide, Associate, Private Clients Jörg Schrade, Lead Partner Eduard Kosavtsev, Senior Associate, both Tax Stefan Lehr, Partner, Antitrust, Competition & Trade Stefan Lüft, Partner, IP Dr Benedikt Forschner, Partner, Labor, Employment & Pensions Dr Markus Kaulartz, Partner Dr Fiona Savary, Counsel Dr Felix Glocker, Senior Associate, all TMC Dr Tilman Niedermaier, Partner Susanne Schwalb, Partner, both Dispute ResolutionPress Con­tact presse@cms-hs. com
25/03/2024
Update Arbeitsrecht April 2024
In unserer Employment Week im Frühjahr haben wir uns mit dem Thema "Re­struk­tur­i­er­ung innerhalb und außerhalb der Insolvenz erfolgreich gestalten" beschäftigt und uns sehr über das große Interesse...
25/03/2024
CMS advises on project financing for land-based terminal in Stade
Hamburg – Hanseatic Energy Hub GmbH (HEH) has achieved financial close for the project financing to develop and realise the planned terminal for liquefied gases in Stade. Total investment is some EUR 1.6 billion. Achieving financial close represents a major milestone for Hanseatic Energy Hub GmbH’s land-based terminal.A multi-dis­cip­lin­ary and multi-location CMS team headed by Dr Hilke Herchen and Dr Holger Kraft advised Hanseatic Energy Hub GmbH on developing the project and on preparations to secure the project financing. This included corporate law advice with a particular focus on developing and optimising corporate governance, and on the associated links to the project financing. This advice marks a continuation of the existing close cooperation between HEH and CMS. The CMS team has been providing advice on an ongoing basis since the start of the project, with support for project development around corporate, operation & maintenance and real estate matters in particular. This has included advising on various shareholders joining the project, with a recent example being Enagás S.A. as industrial partner in June 2023. The CMS team conducted a comprehensive due diligence check to put the project financing on a solid footing. The first expansion phase of the project will see an emission-free terminal begin operating in 2027. Its infrastructure is also approved for bio-LNG and synthetic natural gas (SNG). At a later stage, the project will be switched over to hydrogen-based energy carriers such as ammonia. The planned regasification capacity is 13.3 billion cubic metres per year and the send-out capacity is 21.7 gigawatt. From March 2024 until the onshore terminal becomes operational, Hanseatic Energy Hub GmbH will also accommodate one of the five FSRUs (Floating Storage and Regasification Units) chartered by the German federal government. CMS Germany Dr Hilke Herchen, Lead Partner Dr Holger Kraft, Lead Partner Matthias Sethmann, Principal Counsel Dr Luise Pelzer, Counsel Dr Stefan Kühl, Senior Associate Dr Carl-Friedrich Thoma, Senior Associate Dr Josephine Doll, As­so­ci­ate Domin­ic Zimmer, Associate Dr Christian Seeburger, Associate, all Corporate/M&A Dr Fritz von Hammerstein, Partner Katja Meisel, Senior Associate Jan Gröschel, Senior Associate, all Per­mit­ting Mar­tin Krause, Partner Dr Sebastian Orthmann, Partner Dr Hans Fabian Kiderlen, Principal Coun­sel Chris­toph­er Schmeckel, Senior Associate Wiebke Westermann, Associate, all Real Estate Dr Friedrich von Burchard, Partner, Energy & Climate Change Dorothée Janzen, Part­ner  Chris­toph Zarth, Partner Robin Azinovic, Associate, all Commercial Dr Kerstin Block, Partner, Banking & Finance  Dr Martin Mohr, Partner Dr Olaf Thießen, Principal Counsel, both Tax Dr Sebastian Cording, Partner Dr Anna Lena Füllsack, Senior Associate, both TMC Dr Michael Bauer, Partner Luisa Thomasberger, Associate, both Antitrust, Competition & Trade Dr Philipp Nonnenmühlen, Counsel, Labor, Employment & Pensions Dr Martin Gerecke, Partner, IP Birgit Wagner, Legal Manager, Smart OperationsPress Con­tact presse@cms-hs. com